BP vs Shell: value, quality and relative performance compared

BP offers a better value proposition compared to Shell, while Shell demonstrates stronger financial resilience. Over the past year, Shell has outperformed BP by 1.65 percentage points before accounting for dividends, costs, and foreign exchange fluctuations.

As of September 1, 2026, BP is trading at £5.41, with a forward P/E ratio of 6.8x, a free cash flow (FCF) yield of 14.3%, and a dividend yield of 5.0%. Shell, on the other hand, is priced at €40.16, boasting a forward P/E of 8.0x, an FCF yield of 12.4%, and a dividend yield of 3.3%.

The valuation gap between the two companies is evident. BP is cheaper in terms of forward earnings and cash flow, offering a larger dividend and higher modeled fair-value upside, making it the stronger pure-value leg. Conversely, Shell's advantage lies in its financial stability; its debt-to-equity ratio stands at 40.4%, as opposed to BP's 124.4% as of June 30, 2026. Furthermore, Shell exhibits higher return on equity (ROE) at 14.4% compared to BP's 9.2%.

The relative performance has leaned in favor of Shell, with the pair trading structure favoring Shell if one is long Shell and short BP, resulting in a modest profit. However, both stocks maintain strong buy signals on both daily and weekly technical readings. Shell's weekly Stochastic and StochRSI figures are notably higher than BP's, indicating a more sustained rally.

While Shell possesses superior business quality, BP presents a more affordable valuation and less stretched momentum. This combination suggests a cautious approach towards a BP catch-up thesis rather than an aggressive reversal call. In essence, BP is the better value investment, while Shell is the superior option for long-term growth and quality hedge.

Investors should be mindful of the key risk associated with BP's persistent discount, which may linger due to concerns over leverage and execution. Currently, the relative value framework positions BP as more attractive for mean reversion scenarios, with the critical test being whether BP's valuation discount narrows without exacerbating its balance-sheet risk. Historical data is only available for the past ten years.